These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29747269)

  • 1. [Effect of low-dose or standard-dose conjugated equine estrogen combined with different progesterone on bone density in menopause syndrome women].
    Zuo HL; Deng Y; Wang YF; Gao LL; Xue W; Zhu SY; Ma X; Sun AJ
    Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):243-247. PubMed ID: 29747269
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone protection for early menopausal women in China: standard or half-dose estrogen with progestin? A one-year prospective randomized trail.
    Zhu SY; Deng Y; Wang YF; Xue W; Ma X; Sun A
    Gynecol Endocrinol; 2019 Feb; 35(2):165-169. PubMed ID: 30449208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Half-dose and Standard-dose Conjugated Equine Estrogens Combined with Natural Progesterone or Dydrogesterone on Components of Metabolic Syndrome in Healthy Postmenopausal Women: A Randomized Controlled Trial.
    Xue W; Deng Y; Wang YF; Sun AJ
    Chin Med J (Engl); 2016 Dec; 129(23):2773-2779. PubMed ID: 27900987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Menopausal Hormone Therapy on Bone Mineral Density in Chinese Women: A 2-Year, Prospective, Open-Label, Randomized-Controlled Trial.
    Zuo H; Sun A; Gao L; Xue W; Deng Y; Wang Y; Zhu S; Ma X; Xin H
    Med Sci Monit; 2019 Jan; 25():819-826. PubMed ID: 30690446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological effects of hormone replacement therapy in relation to serum estradiol levels.
    Yasui T; Uemura H; Tezuka M; Yamada M; Irahara M; Miura M; Aono T
    Horm Res; 2001; 56(1-2):38-44. PubMed ID: 11815726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of postmenopausal bone loss by low and conventional doses of calcitriol or conjugated equine estrogen.
    Ongphiphadhanakul B; Piaseu N; Tung SS; Chailurkit L; Rajatanavin R
    Maturitas; 2000 Feb; 34(2):179-84. PubMed ID: 10714913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of estrogen with micronized progesterone on cortical and trabecular bone mass and microstructure in recently postmenopausal women.
    Farr JN; Khosla S; Miyabara Y; Miller VM; Kearns AE
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E249-57. PubMed ID: 23322818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of two different dosages of conjugated equine estrogen in continuous combined hormone replacement therapy with progestin.
    Xing S; Wu Y; Liu J; Xu R; Zhang Z; Wang Y
    Chin Med J (Engl); 2003 Apr; 116(4):584-7. PubMed ID: 12875727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. The Writing Group for the PEPI.
    JAMA; 1996 Nov; 276(17):1389-96. PubMed ID: 8892713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study on two different dosages of conjugated equine estrogen continuously combined with medroxyprogesterone in prevention of postmenopausal osteoporosis].
    Wu Y; Liu J; Xing S; Xu R; Zhang Z; Wang Y
    Zhonghua Fu Chan Ke Za Zhi; 2002 May; 37(5):267-70. PubMed ID: 12133397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of the effects on menopausal symptoms, quality of Life, and cardiovascular risk factors of five different therapy in women at early stage of menopause].
    Xue W; Sun AJ; Zheng TP; Jiang JF; Wang YP; Zhang Y; Chen FL; Deng Y; Wang YF
    Zhonghua Yi Xue Za Zhi; 2016 Aug; 96(29):2327-11. PubMed ID: 27524190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal women.
    Reid IR; Eastell R; Fogelman I; Adachi JD; Rosen A; Netelenbos C; Watts NB; Seeman E; Ciaccia AV; Draper MW
    Arch Intern Med; 2004 Apr; 164(8):871-9. PubMed ID: 15111373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soymilk or progesterone for prevention of bone loss--a 2 year randomized, placebo-controlled trial.
    Lydeking-Olsen E; Beck-Jensen JE; Setchell KD; Holm-Jensen T
    Eur J Nutr; 2004 Aug; 43(4):246-57. PubMed ID: 15309425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmenopausal femur bone loss: effects of a low dose hormone replacement therapy.
    Gambacciani M; Ciaponi M; Cappagli B; Monteleone P; Benussi C; Bevilacqua G; Genazzani AR
    Maturitas; 2003 Jul; 45(3):175-83. PubMed ID: 12818462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alendronate and estrogen effects in postmenopausal women with low bone mineral density. Alendronate/Estrogen Study Group.
    Bone HG; Greenspan SL; McKeever C; Bell N; Davidson M; Downs RW; Emkey R; Meunier PJ; Miller SS; Mulloy AL; Recker RR; Weiss SR; Heyden N; Musliner T; Suryawanshi S; Yates AJ; Lombardi A
    J Clin Endocrinol Metab; 2000 Feb; 85(2):720-6. PubMed ID: 10690882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical study comparing the effects of sequential hormone replacement therapy with oestradiol/dydrogesterone and conjugated equine oestrogen/norgestrel on lipids and symptoms.
    Cieraad D; Conradt C; Jesinger D; Bakowski M
    Arch Gynecol Obstet; 2006 May; 274(2):74-80. PubMed ID: 16491367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
    Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR
    Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
    Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different effects of oral conjugated equine estrogens and transdermal estrogen on undercarboxylated osteocalcin concentration in postmenopausal women.
    Yasui T; Uemura H; Tomita J; Umino Y; Yamada M; Kuwahara A; Matsuzaki T; Maegawa M; Miura M; Irahara M
    Menopause; 2006; 13(4):651-9. PubMed ID: 16837887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Absence of antiosteopenic effect of hormone replacement therapy in postmenopausal women].
    Ortiz Núñez DA; Mengchún López G; Hernández Marín I; Mendoza R; Ayala Ruíz AR
    Ginecol Obstet Mex; 2004 Jul; 72():349-55. PubMed ID: 15469174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.